2-tert-butylhydroquinone has been researched along with Huntington Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Colín-González, AL; Königsberg, M; López-Cervantes, SP; Luna-López, A; Santamaría, A; Silva-Palacios, A; Zazueta, C | 1 |
| Buelna-Chontal, M; Flores, PL; Garibay, C; Hernández-Reséndiz, S; Königsberg, M; Luna-López, A; Ostolga-Chavarría, M; Roldán, FJ; Silva-Palacios, A; Zazueta, C | 1 |
2 other study(ies) available for 2-tert-butylhydroquinone and Huntington Disease
| Article | Year |
|---|---|
Tert-buthylhydroquinone pre-conditioning exerts dual effects in old female rats exposed to 3-nitropropionic acid.
Topics: Animals; Cell Nucleus; Disease Models, Animal; Female; Huntington Disease; Hydroquinones; Neuroprotective Agents; NF-E2-Related Factor 2; NF-kappa B; Nitro Compounds; Oxidative Stress; Propionates; Rats; Signal Transduction | 2017 |
3-NP-induced Huntington's-like disease impairs Nrf2 activation without loss of cardiac function in aged rats.
Topics: Animals; Antihypertensive Agents; Antioxidants; Female; Heart Diseases; Huntington Disease; Hydroquinones; Neuroprotective Agents; NF-E2-Related Factor 2; Nitro Compounds; Oxidative Stress; Propionates; Rats, Wistar | 2017 |